← Leaderboards
Lisa E Manhart
University Of Washington
$10,223,947
Attributed
$12,407,678
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,407,678 · 9
By mechanism
R01$8,389,132 · 3
U19$3,084,780 · 3
R21$843,766 · 2
R13$90,000 · 1
Top collaborators
- David Neal Fredricks7 shared
Most similar at University Of Washington
Same institution · by research overlap
- Jared Baeten$17,463,749
- Raymond Scott McClelland$25,618,064
- Monica Shanta Vavilala$13,806,035
- Jillian Pintye$10,948,659
- John Kinuthia$5,286,949
Others in their field
Top investigators on “Urethritis”
- Martin J Cohn · University Of Florida$11,032,265
- Naoki Yoshimura · University Of Pittsburgh At Pittsburgh$8,471,143
- David Neal Fredricks · Fred Hutchinson Cancer Research Center$8,151,070
- Patricia Jean Johnson · University Of California Los Angeles$7,635,320
- David Emmet Nelson · Indiana University Indianapolis$7,217,123
- Marcia Metzgar Hobbs · University Of North Carolina Chapel Hill$6,784,705
Research focus
UrethritisMaleDetectionInfectionSyndromeWomanMycoplasma GenitaliumClinicBacteriaSexually Transmitted DiseasesEtiologyFemaleRecurrencePathogenChlamydia TrachomatisReportingUrethraReproductive Tract InfectionsLeadOrganismRelative (Related Person)ProgramsAntibioticsPlay
Grant awards (33)
Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance$532,352
R01 · FY2025 · AI · contact PI
Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance$623,944
R01 · FY2024 · AI · contact PI
Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance$618,984
R01 · FY2023 · AI · contact PI
Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance$650,268
R01 · FY2022 · AI · contact PI
Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistance$648,979
R01 · FY2021 · AI · contact PI
Male urethritis: Novel etiologies and natural history$752,056
R01 · FY2018 · AI · contact PI
Urethral microbiome and non-gonococcal urethritis in men who have sex with men (M$361,676
U19 · FY2018 · AI · contact PI
Male urethritis: Novel etiologies and natural history$763,062
R01 · FY2017 · AI · contact PI
Urethral microbiome and non-gonococcal urethritis in men who have sex with men (M$274,721
U19 · FY2017 · AI · contact PI
Male urethritis: Novel etiologies and natural history$776,559
R01 · FY2016 · AI · contact PI
Urethral microbiome and non-gonococcal urethritis in men who have sex with men (M$246,943
U19 · FY2016 · AI · contact PI
Male urethritis: Novel etiologies and natural history$786,346
R01 · FY2015 · AI · contact PI
Urethral microbiome and non-gonococcal urethritis in men who have sex with men (M$306,247
U19 · FY2015 · AI · contact PI
Male urethritis: Novel etiologies and natural history$809,919
R01 · FY2014 · AI · contact PI
Urethral microbiome and non-gonococcal urethritis in men who have sex with men (M$171,502
U19 · FY2014 · AI · contact PI
The Role of Novel Bacteria in Male Urethritis$211,850
R21 · FY2012 · AI · contact PI
The Role of Novel Bacteria in Male Urethritis$267,670
R21 · FY2011 · AI · contact PI
Integrating Depression Screening into HIV-care in Southern India.$159,465
R21 · FY2011 · NR · contact PI
Ureaplasmas in acute and persistent urethritis: clinical implications$130,502
R01 · FY2010 · AI · contact PI
Ureaplasmas in acute and persistent urethritis: clinical implications$545,674
R01 · FY2009 · AI · contact PI
Mycoplasma genitalium Susceptibility and Treatment$518,330
U19 · FY2009 · AI · contact PI
Integrating Depression Screening into HIV-care in Southern India.$204,781
R21 · FY2009 · NR · contact PI
Principles of HIV and STD Research Course$30,000
R13 · FY2009 · AI · contact PI
Ureaplasmas in acute and persistent urethritis: clinical implications$376,399
R01 · FY2008 · AI · contact PI
Mycoplasma genitalium Susceptibility and Treatment$237,326
U19 · FY2008 · AI · contact PI
Principles of STD and HIV Research$20,000
R13 · FY2008 · AI · contact PI
Ureaplasmas in acute and persistent urethritis: clinical implications$374,088
R01 · FY2007 · AI · contact PI
Mycoplasma genitalium Susceptibility and Treatment$219,745
U19 · FY2007 · AI · contact PI
Principles of STD and HIV Research$20,000
R13 · FY2007 · AI · contact PI
M. genitalium Susceptibility and Treatment$263,654
U19 · FY2006 · AI · contact PI
Principles of STD and HIV Research$20,000
R13 · FY2006 · AI · contact PI
M. genitalium Susceptibility and Treatment$257,345
U19 · FY2005 · AI
M. genitalium Susceptibility and Treatment$227,291
U19 · FY2004 · AI